Comment on: Nature and Dimensions of the Systemic Hyper-inflammation and Its Attenuation by Convalescent Plasma in Severe COVID-19.
作者信息
Acosta-Ampudia Yeny, Rojas Manuel, Monsalve Diana M, Rodríguez Yhojan, Ramírez-Santana Carolina, Anaya Juan-Manuel
机构信息
Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogota, Colombia.
Clínica del Occidente, Bogota, Colombia.
出版信息
J Infect Dis. 2021 May 28;223(10):1833-1834. doi: 10.1093/infdis/jiab137.
Abstract
摘要
相似文献
1
Comment on: Nature and Dimensions of the Systemic Hyper-inflammation and Its Attenuation by Convalescent Plasma in Severe COVID-19.关于《严重新型冠状病毒肺炎中全身炎症反应的本质、程度及其通过康复期血浆的缓解》的评论
J Infect Dis. 2021 May 28;223(10):1833-1834. doi: 10.1093/infdis/jiab137.
2
Convalescent plasma for COVID-19 considerations.关于新冠病毒病恢复期血浆的考量
Transfus Apher Sci. 2021 Feb;60(1):102927. doi: 10.1016/j.transci.2020.102927. Epub 2020 Aug 27.
3
Covid-19 convalescent plasma and SARS-CoV-2 viral variants.新冠康复者血浆与严重急性呼吸综合征冠状病毒2病毒变体
Transfus Clin Biol. 2021 Aug;28(3):306. doi: 10.1016/j.tracli.2021.05.008. Epub 2021 May 29.
4
Use of Convalescent Plasma in the Management of COVID-19.康复期血浆在新型冠状病毒肺炎治疗中的应用
Mo Med. 2021 Mar-Apr;118(2):118.
5
How Safe Is COVID-19 Convalescent Plasma?新冠康复者血浆有多安全？
Mayo Clin Proc. 2021 Aug;96(8):2279-2281. doi: 10.1016/j.mayocp.2021.06.011. Epub 2021 Jun 25.
6
Correspondence on 'CONVALESCENT plasma for COVID-19'.关于“COVID-19康复期血浆治疗”的通信
Eur J Clin Invest. 2021 Nov;51(11):e13677. doi: 10.1111/eci.13677. Epub 2021 Sep 13.
7
[COVID-19: blood sufficiency versus convalescent plasma?].[新冠病毒肺炎：血液充足疗法与康复期血浆疗法？]
Rev Med Chil. 2020 Jun;148(6):721-723. doi: 10.4067/S0034-98872020000600721.
8
COVID-19 convalescent plasma therapy and immunodeficiency.新冠康复者血浆疗法与免疫缺陷
Transfus Clin Biol. 2021 Aug;28(3):306-307. doi: 10.1016/j.tracli.2021.05.007. Epub 2021 May 29.
9
In Reply-How Safe Is COVID-19 Convalescent Plasma?回复——新冠康复者血浆有多安全？
Mayo Clin Proc. 2021 Aug;96(8):2281-2282. doi: 10.1016/j.mayocp.2021.06.010. Epub 2021 Jun 25.
10
[Convalescent plasma therapy in COVID-19 patients].[新冠病毒肺炎患者的恢复期血浆治疗]
Medicina (B Aires). 2021;81(2):306.
引用本文的文献
1
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study.疫苗接种状态对美国 SARS-CoV-2 感染后炎症反应动力学的影响：一项前瞻性队列研究。
Lancet Microbe. 2023 Sep;4(9):e692-e703. doi: 10.1016/S2666-5247(23)00171-4. Epub 2023 Aug 7.
2
Rethinking the role of COVID-19 convalescent plasma in the critically ill.重新思考新冠康复者血浆在危重症患者中的作用。
Transfus Apher Sci. 2023 Feb;62(1):103521. doi: 10.1016/j.transci.2022.103521. Epub 2022 Aug 4.
3
Safety and efficacy of convalescent plasma for severe COVID-19: a randomized, single blinded, parallel, controlled clinical study.恢复期血浆治疗重症 COVID-19 的安全性和有效性：一项随机、单盲、平行、对照的临床研究。
BMC Infect Dis. 2022 Jun 27;22(1):575. doi: 10.1186/s12879-022-07560-7.
4
Effectiveness of COVID-19 Convalescent Plasma Infusion Within 48 Hours of Hospitalization With SARS-CoV-2 Infection.新冠病毒感染住院48小时内输注新冠康复者血浆的有效性
Cureus. 2021 Jul 30;13(7):e16746. doi: 10.7759/cureus.16746. eCollection 2021 Jul.
5
Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19.恢复期血浆与 COVID-19 住院患者的死亡率降低和临床病程改善相关。
J Clin Invest. 2021 Oct 15;131(20). doi: 10.1172/JCI151788.
6
The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis.恢复期血浆疗法对 COVID-19 患者死亡率的影响：系统评价和荟萃分析。
Mayo Clin Proc. 2021 May;96(5):1262-1275. doi: 10.1016/j.mayocp.2021.02.008. Epub 2021 Feb 17.
7
Convalescent Plasma Use in the United States was inversely correlated with COVID-19 Mortality: Did Plasma Hesitancy cost lives?美国康复期血浆的使用与新冠病毒疾病死亡率呈负相关：血浆犹豫是否导致了生命损失？
medRxiv. 2021 Apr 16:2021.04.07.21255089. doi: 10.1101/2021.04.07.21255089.
Zotero 插件